Blogger's Note: the full report is extensive but searchable according to numerous quality indices including patient satisfaction, some areas include ovarian cancer specifics (eg. stats...)
CSQI 2013
Cancer System Quality Index (CSQI) 2013
Safe
|
|
Fair, but more work needs to be done. Some processes for a safe cancer
system are in place, and action is under way to address concerns. Better
system measures are needed to understand complications of care, across
all aspects of cancer treatment and from the patient’s perspective. |
|
Effective
|
|
Very good. Cancer services are generally effective and evidence based,
and more Ontarians are receiving treatment based on the best available
evidence. Continued effort is required to achieve targets and
consistency across regions.
|
Accessible
|
|
Very good. More Ontarians are accessing the services they need
despite increases in demand. A focus on patient-centred waits is
required.
|
Responsive
|
|
Good, but the cancer system requires more focus on patients’
and survivors’ quality of life, and consideration of the whole person
and family, both during and after active treatment.
|
Equitable
|
|
Poor. Cancer burden is still higher among those with lower
socioeconomic status. Some variation exists in the use of guidelines for
patients over 70 years old. More work needs to be done, using a
whole-of-society approach to ensure equity.
|
Integrated
|
|
Poor. Services across the system need to be coordinated to
support seamless and effective patient transitions regardless of
location or provider.
|
Efficient
|
|
Fair. Better measures are needed to determine value for money
for all services, while maintaining good health outcomes and seamless
patient care. Use of acute care hospital services at the end of life
remains high, suggesting patients and families may not have adequate
access to appropriate resources and supports. | | |
*
|
|
Very Good
|
|
Good
|
|
Fair
|
|
Poor
|
|
Incomplete Data
|
|
*
These symbols provide an overall assessment of cancer system performance
for each dimension of quality. They include at an aggregate level, an
assessment of performance over time, performance against annual
programmatic targets, jurisdictional comparisons and/or clinical aims
for those measures available in the index. Breadth and depth of
indicators across the patient continuum and type of indicator are taken
into account in the assessment.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.